aTyr Pharma, Inc.
Biotechnology
Healthcare
ATYR
86.49 M shares
NASDAQ US
traded
12 Sep 2025
listed
no
open
5.27
52 week high
6.61
high
6.50
52 week low
0.00
low
5.22
growth
217.37 %
previous Close
5.26
P/E ratio
market cap
466 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
-29.41 %
eps surprise
-21.48 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top